Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. is a Private limited company (Ltd.) registered in United States under 7218511, and its current status with Pennsylvania Department of State is active. The company was incorporated on 19 February 2021 and lists its registered address as United States. 4 shareholders are on record for Mineralys Therapeutics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Pennsylvania Department of State and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Four shareholders are currently on record for Mineralys Therapeutics, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 6.6% — the largest recorded stake — followed by SmallCap World Fund Inc at 2.3%; the remaining 2 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 6.6% | Pennsylvania Department of State | |
| SmallCap World Fund Inc | 2.3% | Pennsylvania Department of State | |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1% | Pennsylvania Department of State | |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.9% | Pennsylvania Department of State |
Officers
5
The Ceo of Mineralys Therapeutics, Inc. currently on record is Jon Congleton; five officers are currently on record for Mineralys Therapeutics, Inc., filed with Pennsylvania Department of State.
The register reports 14 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Mineralys Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Mineralys Therapeutics, Inc.?
Four shareholders are currently on record for Mineralys Therapeutics, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 6.6% — the largest recorded stake — followed by SmallCap World Fund Inc at 2.3%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Mineralys Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Mineralys Therapeutics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Mineralys Therapeutics, Inc. have on record?
4 shareholders are shown on record for Mineralys Therapeutics, Inc..
What is Mineralys Therapeutics, Inc.'s company registration number?
Mineralys Therapeutics, Inc.'s registration number is 7218511, filed with Pennsylvania Department of State in United States. Its current status on the register is active.
Is Mineralys Therapeutics, Inc. still an active company?
Mineralys Therapeutics, Inc.'s status on Pennsylvania Department of State is listed as active.
When was Mineralys Therapeutics, Inc. incorporated?
Mineralys Therapeutics, Inc. was incorporated on 19 February 2021, according to Pennsylvania Department of State.
What is Mineralys Therapeutics, Inc.'s registered address?
The registered address on file for Mineralys Therapeutics, Inc. is United States.
What legal structure is Mineralys Therapeutics, Inc. registered as?
Mineralys Therapeutics, Inc. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of Mineralys Therapeutics, Inc.?
The Ceo of Mineralys Therapeutics, Inc. currently on record is Jon Congleton; five officers are currently on record for Mineralys Therapeutics, Inc., filed with Pennsylvania Department of State. Management authority at Mineralys Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Mineralys Therapeutics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from Pennsylvania Department of State. Zavia's monitoring API can track changes to Mineralys Therapeutics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Mineralys Therapeutics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Mineralys Therapeutics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Pennsylvania Department of State and was last synced on 21 October 2026.